Relapse prevention in schizophrenia: Does group family psychoeducation matter? One-year prospective follow-up field study

International Journal of Psychiatry in Clinical Practice

Volumn 10, Issue 1, 2006, Pages 38-44

  Motlova, Lucie ^a,c   Dragomirecka, Eva ^a   Spaniel, Filip ^a   Goppoldova, Eva ^a   Zalesky, Richard ^a   Selepova, Pavla ^a   Figlova, Zuzana ^b   Höschl, Cyril ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF ECONOMICS   (Czech Republic)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

Family psychoeducation; First episode psychosis; Quality of life; Relapse prevention; Schizophrenia

Indexed keywords

ACUTE PSYCHOSIS; ADULT; ARTICLE; CONTROLLED STUDY; CZECH REPUBLIC; FAMILY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; PRIORITY JOURNAL; PSYCHOEDUCATION; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

EID: 33645133756     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/13651500500305424     Document Type: Article

References (38)

1. Almond S, Knapp M, Francois C, et al. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry 2004;184:346-51.
2. Gilbert PL, Harris MJ, McAdams A, et al. Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Arch Gen Psychiatry 1995;52(3):173-88.
3. Leucht S, Barnes TR, Kissling W, et al. Relapse prevention in schizophrenia with new generation antipsychotics: A systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry 2003;160:1209-22.
4. Schooler NR. Relapse and rehospitalization: Comparing oral and depot antipsychotics. J Clin Psychiatry 2003;64(Suppl 16):14-7.
5. Pitschel-Walz G, Leucht S, Bauml J, et al. The effect of family interventions on relapse and rehospitalization in schizophrenia - A meta-analysis. Schizophr Bull 2001;27(1):73-92.
6. Leff J. First perceptions of treatment: The physician-family-patient network. J Prac Psych Behav Health 1996;2(Suppl 1):10-5.
7. McFarlane WR, Lukens E, Link B. Multiple-family group and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry 1995;52:679-87.
8. Kissling W. Compliance, quality assurance and standards for relapse prevention in schizophrenia. Acta Psychiatr Scand 1994;382:16-24.
9. Kissling W. Compliance, quality management and standards in the treatment of schizophrenia. Neuropsychobiology 1997;35:70-2.
10. Merinder LB, Viuff AG, Laugesen HD, et al. Patient and Relative education in community psychiatry: A randomized controlled trial regarding its effectiveness. Soc Psychiatry Psychiatr Epidemiol 1999;34(6):287-94.
11. Mueser KT, Torrey WC, Lynde D, et al. Implementing evidence-based practices for people with severe mental illness. Behav Modification 2003;27(2):387-411.
12. Basan A, Pitschel-Walz G, Bauml J. Psychoeducational intervention for schizophrenic patients and subsequent long-term ambulatory care. A four-year follow-up. Fortschr Neurol Psychiatr 2000;68(12):537-45.
13. Dixon L, Adams C, Lucksted A. Update on family psychoeducation for schizophrenia. Schizophr Bull 2000;26(1):5-20.
14. Dixon L, McFarlane WR, Lefley H, et al. Evidence-based practices for services to family members of people with psychiatric disabilities. Psychiatr Serv 2001;52:903-10.
15. Ran MS, Xiang MZ, Chan CLW, et al. Effectiveness of psychoeducational intervention for rural Chinese families experiencing schizophrenia. A randomised controlled trial. Soc Psychiatry Psychiatr Epidemiol 2003;38:69-75.
16. Dyck DG, Hendryx MS, Short RA. Service use among patients with schizophrenia in psychoeducational multiple-family group treatment. Psychiatr Serv 2002;53:749-54.
17. Nuechterlein KH, Dawson ME. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 1984;10(2):300-12.
18. Hogarthy GE, Ulrich RF. The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contribution of psychosocial treatment. J Psychiatr Res 1998;32:243-50.
19. Leff J, Kuipers L, Berkowitz RA. Controlled trial of social intervention in the families of schizophrenic patients: two year follow-up. Br J Psychiatry 1985;146:594-600.
20. Možný P, Votýpková P. Expressed emotion, relapse rate and utilization of psychiatric inpatient care in schizophrenia. A study from Czechoslovakia. Soc Psychiatry Psychiatr Epidemiol 1992;27(4):174-9.
21. Kavanagh D. Recent developments in expressed emotion and schizophrenia. Br J Psychiatry 1992;160:601-20.
22. Butzlaff RL, Hooley JM. Expressed emotion and psychiatric relapse: A meta-analysis. Arch Gen Psychiatry 1998;55:547-52.
23. Rosenfarb IS, Nuechterleein KH, Goldstein MJ, et al. Neurocognitive vulnerability, interpersonal criticism, and the emergence of unusual thinking by schizophrenic patients during family transactions. Arch Gen Psychiatry 2000;57(12):1174-9.
24. Motlova L. Psychoeducation as an indispensable complement to pharmacotherapy in schizophrenia. Pharmacopsychiatry; 2000;33(Suppl):47-8.
25. Motlova L, Dragomirecka E, Spaniel F, et al. Quality of life in schizophrenia with recent-onset: Patient-reported outcomes on group family psychoeducation. Abstract. Stating the art: Advancing outcomes research methodology and clinical applications. ISOQOL; 2004. p 65.
26. Endicott J, Spitzer RL, Fleiss JL, et al. The Global Assessment of Functioning scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766-71.
27. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64:663-7.
28. Thompson EE, Neighbors HW, Munday Ch, et al. Length of stay, referral to aftercare and re-hospitalization among psychiatric inpatients. Psychiatr Serv 2003;54:1271-6.
29. Herz MI, Lamberti JS, Mintz J, et al. A program for relapse prevention in schizophrenia: A controlled study. Arch Gen Psychiatry 2000;57(3):277-83.
30. Feldman R, Hornung WP, Prein B, et al. Timing of psychoeducational psychotherapeutic interventions in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 2002;252:115-9.
31. Mubarak AR, Barber JG. Emotional expressiveness and the quality of life of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2003;38(7):380-4.
32. Ritsner M, Ponizovsky A, Endicott J, et al. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: A naturalistic study. Eur Neuropsychopharmacol 2002;12:31-8.
33. Jablensky A. Epidemiology of schizophrenia: The global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci 2000;250:274-85.
34. Browne S, Clarke M, Gervin M, et al. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000;176:173-6.
35. Motlova L, Dragomirecka E, Spaniel F, et al. Schizophrenia and quality of life: Patient-reported outcomes on group family psychoeducation. Psychiatrie 2004;8(Suppl 3):65-8.
36. McGorry PD, Edwards J, Miholopoulos C, et al. EPPIC: An evolving system of early detection and optimal management. Schizophr Bull 1996;22:305-26.
37. Larsen TK, Friis S, Haahr U, et al. Early detection and intervention in first-episode schizophrenia: A critical review. Acta Psychiatr Scand 2001;103:323-34.
38. Carbone S, Harrigan S, McGorry PD, et al. Duration of untreated psychosis and 12-month outcome in first-episode psychosis: The impact of treatment approach. Acta Psychiatr Scand 1999;100:96-104.